Axsome Therapeutics (AXSM) Shares Outstanding (2015 - 2026)

Axsome Therapeutics' Shares Outstanding history runs 12 years deep, the most recent figure standing at $51.4 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 4.48% year-over-year to $51.4 million; the TTM figure through Mar 2026 stood at $51.4 million (up 4.48% YoY), while the FY2025 annual figure was $50.9 million, up 4.55% from the prior year.
• Shares Outstanding came in at $51.4 million for Q1 2026 at Axsome Therapeutics, up from $50.9 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $51.4 million in Q1 2026 to a low of $4.8 million in Q2 2024.
• A 5-year average of $44.2 million and a median of $47.4 million in 2023 frame the typical range for Shares Outstanding.
• Across the five-year window, Shares Outstanding plunged 89.77% in 2024 and jumped 942.13% in 2025, its largest moves.
• Axsome Therapeutics' Shares Outstanding stood at $43.5 million in 2022, then climbed by 8.86% to $47.4 million in 2023, then gained by 2.78% to $48.7 million in 2024, then gained by 4.55% to $50.9 million in 2025, then increased by 1.06% to $51.4 million in 2026.
• According to Business Quant data, Shares Outstanding over the past three periods registered $51.4 million, $50.9 million, and $50.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison